CLINICAL_TRIALS
trial_result
· 2021-06-03
Clinical Trial Update: A Randomized Controlled Test of the Effects of CHI-554 on Fear. [Phase 2]
Summary
Phase 2 randomized trial assessing CHI-554 for anxiety-related fear outcomes; study completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Canopy Growth Corporation | Conditions: Anxiety, Fear | Phase 2 | Status: COMPLETED